Latest news on Alzheimer's
Check out the latest news about Alzheimer's disease research that we carry out at the Barcelonaβeta Brain Research Center (BBRC). Discover the advances in Alzheimer's prevention in which our scientists participate, as well as the news of the Alfa Study, dedicated to the early detection and prevention of the disease.
Sleep fragmentation alters brain structure, especially in women
This research achieved a more precise measurement of sleep quality thanks to the combined use of actigraphy, brain MRI scans, and biomarker analysis.
Blanca Rodríguez defends her PhD thesis on biological aging and its role in Alzheimer’s disease
Her work focused on understanding how telomere length—a key marker of biological aging—influences brain vulnerability and the development of Alzheimer’s disease.
Once again the BBRC brings its science to the international Alzheimer's conference AAIC 2025
Our researchers will present 7 talks and 22 scientific posters during the 5 days of the congress
We are part of an international consortium that publishes the largest proteomic analysis of neurodegenerative diseases ever carried out
The international consortium has analyzed almost 40,000 biological samples to identify biomarkers in Alzheimer’s, Parkinson’s, ALS, and other neurodegenerative diseases.
The death of a partner and financial stress have been linked to an increased risk of Alzheimer's disease and differences in brain structure
This study suggests that certain stressful life events can impact brain health differently depending on gender and educational level
Federica Anastasi awarded BrightFocus Foundation grant to advance personalized approaches to Alzheimer’s disease
The project will last two years and aims to uncover why Alzheimer’s disease affects people in different ways and how its course can be more accurately predicted.
BBRC joins AD-RIDDLE’s second General Assembly in London
This interdisciplinary initiative is designed to provide healthcare providers with a set of innovative tools to improve disease identification and management.
The BBRC hosts and actively participates in the Euro-PAD 2025 symposium
Almost 100 participants gathered to discuss the latest advancements in neuroimaging and biomarkers for Alzheimer’s disease, as well as to share updates from the Euro-PAD initiative over the past year.
New blood biomarker panel accurately detects early Alzheimer’s risk
This fully automated blood test could become a scalable, minimally invasive tool to detect and monitor Alzheimer’s-related changes long before symptoms appear.
